Tatjana Weil

11PUBLICATIONS
65CO-AUTHORS
Proteins and peptidesCharacterisation of biological macromoleculesMolecular targetsBiomolecular modelling and designBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 09, 2026
Identification and Characterization of an In Silico Designed Membrane-Active Peptide with Antiviral Properties.

Pascal von Maltitz, Niek van Hilten, Tatjana Weil

|Oct 03, 2022
Advanced Molecular Tweezers with Lipid Anchors against SARS-CoV-2 and Other Respiratory Viruses.

Tatjana Weil, Abbna Kirupakaran, My-Hue Le

|Sep 03, 2022
Native and activated antithrombin inhibits TMPRSS2 activity and SARS-CoV-2 infection.

Lukas Wettstein, Patrick Immenschuh, Tatjana Weil

|Jul 08, 2022
Peptidomimetic inhibitors of TMPRSS2 block SARS-CoV-2 infection in cell culture.

Lukas Wettstein, Philip Maximilian Knaff, Christian Kersten

|Jun 24, 2022
Inhibitors of Activin Receptor-like Kinase 5 Interfere with SARS-CoV-2 S-Protein Processing and Spike-Mediated Cell Fusion via Attenuation of Furin Expression.

Maja C Mezger, Carina Conzelmann, Tatjana Weil

|Sep 28, 2021
The Molecular Tweezer CLR01 Inhibits Antibody-Resistant Cell-to-Cell Spread of Human Cytomegalovirus.

Sina Brenner, Berenike Braun, Clarissa Read

Pageof 2

Frequent Collaborators

9 joint publications

Jan Münch

5 joint publications

Lukas Wettstein

4 joint publications

Manfred Frick

4 joint publications

Janis Müller